Safety profiles of new xanthine oxidase inhibitors: A post-marketing study.
CONCLUSION: The strength of the associations of XO inhibitors with adverse events is variable, and further studies are required to evaluate the identified signals.
PMID: 33560211 [PubMed - as supplied by publisher]
Source: International Journal of Clinical Pharmacology and Therapeutics - Category: Drugs & Pharmacology Tags: Int J Clin Pharmacol Ther Source Type: research
More News: Allopurinol | Databases & Libraries | Drugs & Pharmacology | Japan Health | Liver | Medical Devices | Skin | Study | Urology & Nephrology